Which is a more important risk factor for L-DOPA-induced dyskinesia, age at onset of Parkinson's disease or age at L-DOPA treatment for Parkinson's disease?

被引：0
|
作者：
Kimura, Tamaki [1 ]
Tomiyama, Masahiko [1 ]
Arai, Akira [1 ]
Suzuki, Chieko [1 ]
Shouji, Mikio [1 ]
机构：
[1] Hirosaki Univ, Hirosaki, Aomori, Japan
来源：
NEUROSCIENCE RESEARCH | 2008年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 50 条
  • [41] Reduction of L-DOPA-induced dyskinesia in animal models of Parkinson disease
    Nature Clinical Practice Neurology, 2009, 5 (2): : 62 - 62
  • [42] An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
    Huh, Eugene
    Choi, Din Gyu
    Sim, Yeomoon
    Oh, Myung Sook
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 10
  • [43] Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
    Sano, Hiromi
    Nambu, Atsushi
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [44] Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease
    Ryu, Young-Kyoung
    Park, Hye-Yeon
    Go, Jun
    Choi, Dong-Hee
    Kim, Yong-Hoon
    Hwang, Jung Hwan
    Noh, Jung-Ran
    Lee, Tae Geol
    Lee, Chul-Ho
    Kim, Kyoung-Shim
    MOLECULAR NEUROBIOLOGY, 2018, 55 (07) : 5715 - 5726
  • [45] Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson’s Disease and L-DOPA-Induced Dyskinesia
    D. P. Ferrari
    M. Bortolanza
    E. A. Del Bel
    Neurotoxicity Research, 2021, 39 : 705 - 719
  • [46] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
    Saiki, H.
    Matsumoto, S.
    MOVEMENT DISORDERS, 2012, 27 : S50 - S50
  • [47] Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson's Disease and L-DOPA-Induced Dyskinesia
    Ferrari, D. P.
    Bortolanza, M.
    Del Bel, E. A.
    NEUROTOXICITY RESEARCH, 2021, 39 (03) : 705 - 719
  • [48] Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease
    Boi, Laura
    Pisanu, Augusta
    Greig, Nigel H.
    Scerba, Michael T.
    Tweedie, David
    Mulas, Giovanna
    Fenu, Sandro
    Carboni, Ezio
    Spiga, Saturnino
    Carta, Anna R.
    MOVEMENT DISORDERS, 2019, 34 (12) : 1818 - 1830
  • [49] Metformin Inhibits the Development of l-DOPA-Induced Dyskinesia in a Murine Model of Parkinson’s Disease
    Young-Kyoung Ryu
    Hye-Yeon Park
    Jun Go
    Dong-Hee Choi
    Yong-Hoon Kim
    Jung Hwan Hwang
    Jung-Ran Noh
    Tae Geol Lee
    Chul-Ho Lee
    Kyoung-Shim Kim
    Molecular Neurobiology, 2018, 55 : 5715 - 5726
  • [50] L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room
    Paul, Rajib
    Borah, Anupom
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (09): : 1989 - 1997
12345